To study whether ISG15 affects HCC cell proliferation by regulating γ‐GCL activity, a GCL inhibitor buthionine sulfoximine (BSO) was used,[36] which significantly suppressed γ‐GCL activity (Figure S3A, Supporting Information). The gene discussed is ISG15; the disease is hepatocellular carcinoma.